ICON Public Limited Company - ICLR

SEC FilingsOur ICLR Tweets

About Gravity Analytica

Recent News

  • 12.11.2025 - New ICON survey shows sites face growing delays and communication gaps during study startup
  • 12.11.2025 - Research paints China as ‘global innovation powerhouse’
  • 12.11.2025 - China becoming dominant force in biotech sector, survey says
  • 12.10.2025 - The CRA role’s co-evolution with clinical trial technology
  • 12.10.2025 - Accelerating timelines and reducing cost in early clinical drug development
  • 12.09.2025 - Bold moves
  • 12.09.2025 - ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
  • 12.09.2025 - ICON 2025 global biotech survey
  • 12.03.2025 - Transforming central labs with automation and AI: setting new standards for modern trials
  • 12.02.2025 - ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Recent Filings

  • 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 11.12.2025 - EX-99.1 EX-99.1
  • 11.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors